World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
24959
World Ranking
16107
National Ranking
842

Bernd Dörken publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bernd Dörken sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 380 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Bernd Dörken D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bernd Dörken sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Bernd Dörken is affiliated with Charité - University Medicine Berlin in Germany. Their research spans several interconnected fields within biomedical science, with a focus on both clinical and molecular aspects of disease.

The main fields of study explored by Dörken include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Dörken's work also extends into specialized subfields such as:

  • Hematology
  • Molecular Biology
  • Oncology

The scientist addresses multiple research topics, particularly within cancer biology and treatment, including:

  • Acute Myeloid Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Histone Deacetylase Inhibitors Research
  • Cancer-related Molecular Pathways
  • Pancreatic and Hepatic Oncology Research
  • RNA modifications and cancer

Dörken has contributed to recent publications, including:

  • "Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study," 2023, Annals of Hematology
  • "Withdrawal: p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity," 2023, Journal of Biological Chemistry

The scientist often collaborates with other researchers in their field. Frequent co-authors include:

  • Dietger Niederwieser
  • Thomas Lang
  • Rainer Krahl
  • Thomas Heinicke
  • Georg Maschmeyer

Dörken's publications have appeared primarily in the following venues:

  • Annals of Hematology
  • Journal of Biological Chemistry

Best Publications

  • Oncogene-induced senescence as an initial barrier in lymphoma development

    Melanie Braig;Soyoung Lee;Christoph Loddenkemper;Cornelia Rudolph

  • Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

    Volker Diehl;Jeremy Franklin;Michael Pfreundschuh;Bernd Lathan

  • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri

  • Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

    R C Bargou;F Emmerich;D Krappmann;K Bommert

  • Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′-Epidoxorubicin in 14 Patients with Advanced Solid Tumors

    Andreas Stephan Lübbe;Christian Bergemann;Hanno Riess;Folke Schriever

  • Senescence-associated reprogramming promotes cancer stemness

    Maja Milanovic;Dorothy N. Y. Fan;Dimitri Belenki;J. Henry M. Däbritz

  • Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

    Andreas Engert;Heinz Haverkamp;Carsten Kobe;Jana Markova

  • Synthetic lethal metabolic targeting of cellular senescence in cancer therapy

    Jan R. Dörr;Yong Yu;Maja Milanovic;Gregor Beuster

  • Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma

    Franziska Jundt;Ioannis Anagnostopoulos;Reinhold Förster;Stephan Mathas

  • Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

    Uwe Pelzer;Ingo Schwaner;Jens Stieler;Mathias Adler

  • Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

    Rami Rahal;Mareike Frick;Rodrigo Romero;Joshua M Korn

  • Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

    Björn Lamprecht;Korden Walter;Stephan Kreher;Stephan Kreher;Raman Kumar

  • PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma

    Matthias Pfeifer;Michael Grau;Dido Lenze;Sören-Sebastian Wenzel

  • Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines

    Stephan Hailfinger;Hendrik Nogai;Christiane Pelzer;Maike Jaworski

  • Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)

    Stephan H.K. Oertel;Erik Verschuuren;Petra Reinke;Kristin Zeidler

  • Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.

    Franziska Jundt;Kristina Schulze Pröbsting;Ioannis Anagnostopoulos;Gwendolin Muehlinghaus

  • CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

    Marianne Sinn;Marcus Bahra;Torsten Liersch;Klaus Gellert

  • Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

    T D Kim;D Rea;M Schwarz;P Grille

  • Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.

    R C Bargou;C Wagener;K Bommert;M Y Mapara

  • Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

    Stephan Mathas;Martin Janz;Martin Janz;Franziska Hummel;Michael Hummel

Frequent Co-Authors

Peter T. Daniel
Peter T. Daniel Max Delbrück Center for Molecular Medicine
Michael Hummel
Michael Hummel Charité - University Medicine Berlin
Ioannis Anagnostopoulos
Ioannis Anagnostopoulos Charité - University Medicine Berlin
Harald Stein
Harald Stein Charité - University Medicine Berlin
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Martin Lipp
Martin Lipp Max Delbrück Center for Molecular Medicine
Christoph Loddenkemper
Christoph Loddenkemper Charité - University Medicine Berlin
Claus Scheidereit
Claus Scheidereit Max Delbrück Center for Molecular Medicine
Petra Reinke
Petra Reinke Berlin-Brandenburger Centrum für Regenerative Therapien

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA can also mean exploring alternative pathways and online programs. Many students start by earning a nursing degree, as becoming a Registered Nurse (RN) remains a popular entry route. For those looking to advance quickly and affordably, researching what is the cheapest rn to bsn program online can help minimize costs without sacrificing quality.

If you hold a non-nursing bachelor’s degree but wish to enter advanced practice nursing, direct entry msn programs allow a faster transition, making it possible to enter the field with flexibility and minimal prerequisites.

Those concerned about admissions difficulty can consider nursing programs with high acceptance rates, which offer more accessible entry points and can help open doors to a healthcare career.

Healthcare isn’t limited to clinical roles—fields like medical billing and coding are also in high demand. There are options for individuals seeking administrative careers, with many accredited programs offering financial support, as detailed in financial aid for medical billing and coding.

Best Scientists Citing Bernd Dörken

Trending Scientists

Recently Published Articles